$10,000 invested in these ASX healthcare shares 5 years ago is now worth…

These healthcare stocks have brought big returns for investors 

| More on:
Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX healthcare shares are often regarded as less represented in the Australian economy. 

While this is true compared to financials (big banks) and resources (mining giants), there are healthcare shares have brought big returns for investors in recent times. 

Projecting which ones will produce these big returns is another challenge. 

In the last 5 years, the S&P/ASX 200 Health Care (ASX:XHJ) index has grown just 2%. 

Here are two of the outliers.

Pro Medicus Ltd (ASX: PME)

Pro Medicus Ltd (ASX: PME) is a provider of medical imaging technology globally. 

The company is recognised as a leading supplier of radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualisation solutions for medical practices and hospitals.

Its share price lay dormant for many years, before gaining some momentum in the late 2010s. 

Five years ago its share price sat at roughly $25.

Since then, it has seen rapid growth to become one of the largest healthcare stocks by market capitalisation in Australia. 

For holders of this stock, it's been the gift that keeps on giving. 

Pro Medicus was the second best performing ASX 200 healthcare shares last financial year, with 99% share price growth.

At the time of writing, its share price sits at $314.20. 

A $10,000 investment in Pro Medicus five years ago would be worth approximately $124,290 today – a 1,143% return.

This is before taking into consideration any dividends or reinvented earnings. 

Can the bull run continue?

Its success has come on the back of high margins, zero debt, a sticky client base, and strong earnings growth.

However, based on reporting from The Motley Fool's Brownwyn Allen, experts believe its share price could be overvalued right now. 

Sigma Healthcare Ltd (ASX: SIG)

Sigma Healthcare engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label.

The share price for this ASX healthcare stock remained flat for much of the last five years, before taking off in 2024. 

In total, it is up 367.19% over the past 5 years. 

This included 130% in FY25 alone, making it the best performing healthcare stock. 

A $10,000 investment in Sigma Healthcare five years ago would be worth approximately $46,718.75 today – a 367% return.

Is it still a buy?

Yesterday my colleague Bernd Struben reported that one broker in particular doesn't recommend adding more shares to your portfolio today.

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Female scientist working in a laboratory.
Healthcare Shares

These three biotechs show how the sector can produce huge outsized gains, but are they still good value?

These drug developers' shares are trading near 12-month highs.

Read more »

A medical specialist holds a red heart connected via technology and artificial intelligence.
Healthcare Shares

This biotech is approaching 20-bagger status within a year and the good news continues to come

This company has just won approval to go ahead with a key clinical trial.

Read more »

An investor sits at a table in front of her laptop with a party hat on her head and a cake next to her symbolising new year's eve but the 4DS Memory share price is plunging so she looks very disappointed and depressed
Healthcare Shares

$5 billion ASX 200 healthcare stock tumbling on CEO exit

Investors are bidding down the ASX 200 healthcare giant on Thursday. Let’s see why.

Read more »

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »

Child with superhero mask and cape flies after jumping on sofa
AI Stocks

3 of the fastest-growing stocks on the planet in 2025

These stocks soared in 2025.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Could CSL shares outperform the ASX 200 in 2026?

After shocking investors in 2025, CSL shares may be setting up for a comeback. Here’s why 2026 could look better.

Read more »